Literature DB >> 24957308

Cognitive function of patients with adult moyamoya disease.

Yoshio Araki1, Yasushi Takagi2, Keita Ueda3, Shiho Ubukata3, Junko Ishida4, Takeshi Funaki2, Takayuki Kikuchi2, Jun C Takahashi2, Toshiya Murai3, Susumu Miyamoto2.   

Abstract

BACKGROUND: Neurocognitive impairment is one of several unsolved social issues faced by patients with moyamoya disease. Although efforts have been made to investigate cognitive function using neuropsychologic tasks, generalizability has been limited. Here, in a preliminary study, we used structured neuropsychologic tasks to establish a standardized neuropsychologic assessment for adult moyamoya patients with and without difficulty in social independence.
METHODS: Ten patients with neuroradiologically confirmed adult moyamoya disease (3 male, 7 female) participated. Half of all subjects did not have difficulty with social independence (group 1) and the others had (group 2). Group differences were evaluated after basic cognitive abilities and frontal lobe function were tested.
RESULTS: Although the mean age of group 1 was substantially higher than that of group 2, disease duration did not differ significantly between groups. Means scores for intelligence functions including all subtests for basic cognitive abilities were higher in group 1 compared with group 2. Scores from only 2 frontal lobe evaluation tasks (Trail Making Test B and Theory of Mind) were significantly different between groups.
CONCLUSIONS: This preliminary study provides a profile of neurocognitive dysfunction in adult patients with moyamoya disease using structured neuropsychologic tasks. A broad range of cognitive functions was disrupted particularly in the patients who had difficulty with social independence. To obtain stronger evidence regarding neurocognitive dysfunction in patients with moyamoya disease, a multicenter prospective study is essential.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya disease; adult; cognitive impairment; neuropsychologic tests

Mesh:

Year:  2014        PMID: 24957308     DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.032

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  10 in total

1.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
Journal:  Neurosurg Rev       Date:  2021-01-08       Impact factor: 3.042

2.  Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.

Authors:  Yoshio Araki; Takashi Mamiya; Naotoshi Fujita; Kenji Uda; Kinya Yokoyama; Fumiaki Kanamori; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuch; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Takafumi Tanei; Masaki Sumitomo; Sho Okamoto; Takashi Izumi; Katsuhiko Kato; Ryuta Saito
Journal:  Neurosurg Rev       Date:  2022-03-23       Impact factor: 3.042

Review 3.  Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): study protocol.

Authors:  Yasushi Takagi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 4.  Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.

Authors:  Takeshi Funaki; Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-21       Impact factor: 1.742

5.  Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia.

Authors:  Da-Peng Wang; Qi Lin; Kai Kang; Yi-Fang Wu; Shao-Hua Su; Jian Hai
Journal:  Ann Transl Med       Date:  2021-02

6.  Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.

Authors:  Jian Sun; Zhiyong Shi; Lebao Yu; Yujie Wen; Dong Zhang
Journal:  BMC Neurol       Date:  2022-01-06       Impact factor: 2.474

7.  Characterizing the neurocognitive profiles of children with moyamoya disease using the Das Naglieri cognitive assessment system.

Authors:  Yusuke Kusano; Takeshi Funaki; Keita Ueda; Noyuri Nishida; Kanade Tanaka; Susumu Miyamoto; Shuichi Matsuda
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

8.  Preoperative brain connectome predicts postoperative changes in processing speed in moyamoya disease.

Authors:  Mengxia Gao; Charlene L M Lam; Wai M Lui; Kui Kai Lau; Tatia M C Lee
Journal:  Brain Commun       Date:  2022-08-20

9.  Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.

Authors:  Zhiyong Shi; Yu-Jie Wen; Zheng Huang; Le-Bao Yu; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2020-03-25

10.  Decreased frontal white-matter diffusion and improved cognitive flexibility after burr-hole surgery in moyamoya angiopathy.

Authors:  Lionel Calviere; Paul Loubiere; Melanie Planton; Vanessa Cazzola; Isabelle Catalaa; Helene Mirabel; Jean Christophe Sol; Fabrice Bonneville
Journal:  BMC Neurol       Date:  2020-01-20       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.